Variant report
Variant | esv2763534 |
---|---|
Chromosome Location | chr6:12196490-12198774 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9471162 | chr6:12196490-12196491 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs548185861 | chr6:12196527-12196528 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs374406908 | chr6:12196530-12196531 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs539081533 | chr6:12196539-12196540 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs9380894 | chr6:12196604-12196605 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
6 | rs372412158 | chr6:12196630-12196631 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs550493732 | chr6:12196666-12196667 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs570301337 | chr6:12196684-12196685 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs114915593 | chr6:12196740-12196741 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs553144291 | chr6:12196741-12196742 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs566965224 | chr6:12196790-12196791 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs535447089 | chr6:12196846-12196847 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs377742480 | chr6:12196859-12196860 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs376109152 | chr6:12196870-12196871 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs555753313 | chr6:12196886-12196887 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs575744592 | chr6:12196890-12196891 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs1040992 | chr6:12196910-12196911 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs558535678 | chr6:12196933-12196934 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs1040993 | chr6:12196938-12196939 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
20 | rs76645982 | chr6:12196939-12196940 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs559153353 | chr6:12196957-12196958 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs180998580 | chr6:12197018-12197019 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs142085565 | chr6:12197045-12197046 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs561329564 | chr6:12197064-12197065 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs530463192 | chr6:12197120-12197121 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs78671317 | chr6:12197141-12197142 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs570415307 | chr6:12197166-12197167 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs1040994 | chr6:12197213-12197214 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundancedisease |
29 | rs559080391 | chr6:12197289-12197290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs566823113 | chr6:12197322-12197323 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs535929544 | chr6:12197434-12197435 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs219973 | chr6:12197452-12197453 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs569272640 | chr6:12197457-12197458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs185162594 | chr6:12197522-12197523 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs558452994 | chr6:12197523-12197524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs189969125 | chr6:12197572-12197573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs534106251 | chr6:12197601-12197602 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs554323519 | chr6:12197606-12197607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs140203413 | chr6:12197620-12197621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs182555321 | chr6:12197646-12197647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs553894297 | chr6:12197649-12197650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs144028523 | chr6:12197658-12197659 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs146448372 | chr6:12197665-12197666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs543813832 | chr6:12197671-12197672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs566736036 | chr6:12197672-12197673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs141048840 | chr6:12197678-12197679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs533277571 | chr6:12197685-12197686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs376729092 | chr6:12197748-12197749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs546605772 | chr6:12197762-12197763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs11385503 | chr6:12197785-12197786 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 20164920 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 21183584 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Bladder cancer | 21909424 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Williams Syndrome | 20824207 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:12176200-12203400 | Weak transcription | A549 | lung |
2 | chr6:12185800-12200800 | Weak transcription | Aorta | Aorta |
3 | chr6:12196000-12197000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
4 | chr6:12196200-12196800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
5 | chr6:12196200-12197000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
6 | chr6:12196200-12197000 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
7 | chr6:12196200-12197000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
8 | chr6:12196200-12197000 | Enhancers | NHEK | skin |
9 | chr6:12196400-12196800 | Enhancers | HSMMtube | muscle |
10 | chr6:12196400-12196800 | Enhancers | Osteobl | bone |
11 | chr6:12196400-12197000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
12 | chr6:12196400-12197200 | Enhancers | HSMM | muscle |
13 | chr6:12196600-12197000 | Enhancers | HUVEC | blood vessel |
14 | chr6:12196600-12197200 | Enhancers | NH-A | brain |
15 | chr6:12196800-12200600 | Weak transcription | Osteobl | bone |
16 | chr6:12197000-12200600 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |